Detalhe da pesquisa
1.
Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.
J Biol Chem
; 289(41): 28249-59, 2014 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25170076
2.
Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.
Eur J Prev Cardiol
; 31(7): 856-865, 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348689
3.
Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK Biobank.
Atherosclerosis
; 389: 117437, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219651
4.
Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States.
J Manag Care Spec Pharm
; 29(5): 519-529, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37121256
5.
Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry.
Int J Cardiol
; 370: 279-286, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36216094
6.
Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry.
Eur Heart J Qual Care Clin Outcomes
; 8(4): 469-477, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725113
7.
Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry.
ESC Heart Fail
; 9(6): 4209-4218, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106548
8.
OUTSTEP-HF: randomised controlled trial comparing short-term effects of sacubitril/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction.
Eur J Heart Fail
; 23(1): 127-135, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314487
9.
PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study.
Open Heart
; 8(2)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670830
10.
Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
Clin Ther
; 30(10): 1782-93, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19014834
11.
Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study.
J Clin Hypertens (Greenwich)
; 10(3): 185-94, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18326958
12.
Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2).
Hypertension
; 69(1): 189-196, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27872236
13.
Biomarkers for cardiovascular risk assessment in autoimmune diseases.
Proteomics Clin Appl
; 9(1-2): 48-57, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25523513
14.
Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
Vasc Health Risk Manag
; 5: 883-92, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19898644
15.
Public health value of fixed-dose combinations in hypertension.
Blood Press Suppl
; 1: 5-14, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18705530
16.
Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy.
Blood Press Suppl
; 1: 15-23, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18705531
17.
Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.
Hypertension
; 51(6): 1617-23, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18426991
18.
[Monoclonal antibodies: Comparative methods for in vitro production]
ALTEX
; 9(1): 15-24, 1992.
Artigo
em Inglês
| MEDLINE | ID: mdl-11178564